KAREN CHERINKA: Open Payments
NPI 1093186348 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 11 payments from 5 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 3 | $49 |
| Dexcom, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: CAPLYTA, Wegovy, ZEPBOUND, Dexcom G6 Transmitter, Ozempic, SHINGRIX.
Industry payments across PA — which companies pay providers there.
